Stock Events

Stock Events

Wuxi Biologics (Cayman) 

฿3.12
69
+฿0.00+0% 05:54 Today

Statistics

Day High
3.14
Day Low
3.1
52W High
3.26
52W Low
1.8
Volume
1,002
Avg. Volume
2,269
Mkt Cap
18.72B
P/E Ratio
0.54
Dividend Yield
-
Dividend
-

Upcoming

Earnings

25AugExpected
Q2 2025
Q4 2025
Q2 2026
2.05
2.34
2.63
2.92
Expected EPS
2.16376677
Actual EPS
2.788854948

Financials

22.53%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
98.29BRevenue
22.14BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow WUXI13.BK. It's not an investment recommendation.
Apple
12
AAPL
Microsoft
11
MSFT
NVIDIA
11
NVDA
Tesla
9
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Sartorius
SARTF
Mkt Cap14.69B
Sartorius Stedim Biotech is a supplier of equipment and services for biopharmaceutical manufacturing, competing in the bioprocessing space with Wuxi Biologics.
Charles River Laboratories International
CRL
Mkt Cap13.77B
Charles River Laboratories offers a broad range of services to support the pharmaceutical and biotech industries, including biologics testing services.
Thermo Fisher Scientific
TMO
Mkt Cap226.94B
Thermo Fisher Scientific provides bioproduction and bioprocessing products and services, competing with Wuxi Biologics in the supply of critical biomanufacturing technologies.
Danaher
DHR
Mkt Cap145.98B
Danaher, through its subsidiaries like Cytiva, competes in the bioprocessing space by providing technologies and services for biomanufacturing.
Bio-Rad Laboratories
BIO
Mkt Cap10.32B
Bio-Rad Laboratories offers products and services in the field of life science research and clinical diagnostics, competing in the biologics tools and services market.
IQVIA
IQV
Mkt Cap44.07B
IQVIA provides advanced analytics, technology solutions, and contract research services to the life sciences industry, competing in the broader biopharmaceutical services market.
Pfizer
PFE
Mkt Cap162.16B
Pfizer, through its contract manufacturing organization Pfizer CentreOne, competes in the biologics manufacturing and development services sector.
Gilead Sciences
GILD
Mkt Cap187.23B
Gilead Sciences, while primarily a biopharmaceutical company, competes for resources, talent, and market share in the biologics sector, particularly in areas of overlapping therapeutic interest.

About

WUXI BIOLOGICS CAY NEW
Show more...
CEO
Zhisheng Chen
Employees
13252
Country
Cayman Islands
ISIN
TH0171121005

Listings

MU
DE
1FW.MU
STU
DE
1FW1.STU
STU
DE
1FW2.STU
MU
DE
1FW1.MU

0 Comments

Share your thoughts

FAQ

What is Wuxi Biologics (Cayman) stock price today?▼
The current price of WUXI13.BK is ฿3.12 THB — it has increased by +0% in the past 24 hours. Watch Wuxi Biologics (Cayman) stock price performance more closely on the chart.
What is Wuxi Biologics (Cayman) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Thailand Exchange exchange Wuxi Biologics (Cayman) stocks are traded under the ticker WUXI13.BK.
What is Wuxi Biologics (Cayman) market cap?▼
Today Wuxi Biologics (Cayman) has the market capitalization of 18.72B
When is the next Wuxi Biologics (Cayman) earnings date?▼
Wuxi Biologics (Cayman) is going to release the next earnings report on March 23, 2027.
What were Wuxi Biologics (Cayman) earnings last quarter?▼
WUXI13.BK earnings for the last quarter are 2.79 THB per share, whereas the estimation was 2.16 THB resulting in a +28.89% surprise. The estimated earnings for the next quarter are N/A THB per share.
What is Wuxi Biologics (Cayman) revenue for the last year?▼
Wuxi Biologics (Cayman) revenue for the last year amounts to 98.29B THB.
What is Wuxi Biologics (Cayman) net income for the last year?▼
WUXI13.BK net income for the last year is 22.14B THB.
How many employees does Wuxi Biologics (Cayman) have?▼
As of September 07, 2026, the company has 13,252 employees.
In which sector is Wuxi Biologics (Cayman) located?▼
Wuxi Biologics (Cayman) operates in the Health & Wellness sector.
When did Wuxi Biologics (Cayman) complete a stock split?▼
The last stock split for Wuxi Biologics (Cayman) was on December 10, 2020 with a ratio of 3:1.
Where is Wuxi Biologics (Cayman) headquartered?▼
Wuxi Biologics (Cayman) is headquartered in Wuxi, Cayman Islands.